WOAI-TV: Antiretroviral drug shows potential for Alzheimer’s disease treatment in early clinical trials

August 9, 2024

This news segment mentions that scientists from The University of Texas Health Science Center at San Antonio led a pilot study showing that the antiretroviral drug lamivudine shows potential for Alzheimer’s disease treatment.   Watch Now

Clinical Trials Arena: UT Health San Antonio-led study shows lamivudine’s potential in Alzheimer’s

August 9, 2024

A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article.   Read More

For Worth Star-Telegram: UT Health San Antonio study — HIV drug may be effective against Alzheimer’s disease

August 9, 2024

A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article.   Read More

MSN.com: UT Health San Antonio study: HIV drug may be effective against Alzheimer’s disease

August 9, 2024

A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article.   Read More

Yahoo! Finance: UT Health San Antonio-led study shows lamivudine’s potential in Alzheimer’s

August 9, 2024

A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article.   Read More

San Antonio Express-News: UT Health San Antonio study — HIV drug may be effective against Alzheimer’s disease

August 8, 2024

A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article.   Read More